Disposable Syringes Market By Product Type (Luer Lock Syringes, Luer Slip Syringes), By Material (Plastic Syringes, Glass Syringes), By Capacity (0.5-5 ml, 5.1-10 ml, 10.1-20 ml, Above 20 ml), By End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers), By Application (Insulin Administration, Vaccination, Intravenous Administration); Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Disposable Syringes Market was valued at USD 13.0 billion in 2023 and will surpass USD 20.8 billion by 2030; growing at a CAGR of 7.0% during 2024 - 2030.

The disposable syringes market is experiencing robust growth driven by rising healthcare demands, increased safety measures, and the increasing need for efficient drug delivery systems. As a key tool in medical procedures ranging from vaccinations to chronic disease management, disposable syringes are favored for their convenience, safety, and ease of use. Innovations in syringe design, material improvements, and the need for compliance with global healthcare standards continue to drive the market's evolution. The market is segmented into various types, materials, capacities, end-users, and applications, each catering to a specific need within the healthcare sector.

Luer Lock Syringes Segment Is Largest Owing to Their Secure Fit

The Luer Lock Syringes segment is the largest in the disposable syringes market. This is due to the secure connection these syringes offer, which minimizes the risk of disconnection during injections. They are extensively used in medical settings for a wide range of applications, including intravenous administration, insulin injections, and vaccination. The mechanism ensures a safe and leak-proof connection with the needle, making them ideal for both healthcare providers and patients who need reliable drug delivery systems.

Luer lock syringes are preferred by hospitals and clinics because of their secure and tamper-resistant nature, which enhances patient safety. Their dominance in the market is also attributed to their compatibility with various types of needles and their easy use in critical medical procedures. Furthermore, the growing demand for safe drug delivery in high-stakes environments such as hospitals and clinics fuels the segment’s growth.

Plastic Syringes Segment Is Largest Owing to Cost-Effectiveness and Versatility

Among the material segments, plastic syringes hold the largest share. Plastic syringes are widely adopted in healthcare settings due to their cost-effectiveness, lightweight nature, and versatile usage. These syringes are typically made from materials such as polypropylene, which are not only durable but also easy to manufacture, making them a cost-efficient choice for both healthcare providers and manufacturers. The convenience of disposable plastic syringes also ensures compliance with safety standards, as they reduce the risk of infection associated with reusable devices.

Plastic syringes are preferred for their wide availability, especially in emergency situations, vaccinations, and chronic disease management such as insulin delivery. Their dominance is further reinforced by their use in mass vaccination campaigns and routine medical procedures. The global adoption of disposable plastic syringes continues to rise, fueled by the ongoing need for cost-effective healthcare solutions.

0.5-5 ml Syringes Segment Is Largest Owing to Widespread Use in Insulin Administration

In terms of capacity, the 0.5-5 ml syringes segment is the largest. These syringes are predominantly used for administering insulin, a key treatment for diabetes, which affects a significant portion of the global population. Insulin delivery systems require syringes with precise dosage measurements, and the 0.5-5 ml syringes provide optimal volume for most insulin injections. The growing prevalence of diabetes and other chronic conditions further accelerates demand for syringes in this capacity range.

The 0.5-5 ml syringes are highly popular due to their compact size and ability to accurately deliver small doses of medication, particularly in patients managing chronic diseases. As more people are diagnosed with diabetes and other conditions requiring injectable medication, the demand for these syringes continues to rise globally.

Hospitals Segment Is Largest Owing to High-Volume Use and Critical Care Needs

The hospitals segment is the largest in terms of end-users. Hospitals use disposable syringes in high volumes for a variety of medical procedures, from emergency care to routine vaccinations and intravenous drug administration. Hospitals are among the largest consumers of syringes due to the critical care provided to a broad range of patients, requiring frequent and accurate drug delivery.

Hospitals continue to dominate the disposable syringes market due to their role in patient care, surgery, and the growing demand for healthcare services. The rise of chronic diseases and the need for immunization campaigns has led to an increase in the consumption of disposable syringes in hospitals. Hospitals also favor these syringes for their ease of use, which helps streamline medical procedures and reduce the likelihood of errors.

Insulin Administration Segment Is Largest Owing to Rising Diabetes Prevalence

The insulin administration segment is the largest application for disposable syringes, driven by the increasing number of people diagnosed with diabetes worldwide. As the incidence of diabetes continues to rise globally, the need for insulin delivery systems has escalated. Disposable syringes provide a simple, safe, and effective means for self-administering insulin, particularly among patients with Type 1 and Type 2 diabetes.

The rising global awareness about diabetes management and the adoption of homecare solutions have significantly contributed to the growth of this segment. Patients prefer disposable syringes for insulin administration because they are easy to use, cost-effective, and available in precise dosing ranges, making them ideal for daily management of the condition.

Asia-Pacific Region Is Fastest Growing Owing to Improving Healthcare Infrastructure

The Asia-Pacific region is the fastest-growing market for disposable syringes. This growth can be attributed to rapid improvements in healthcare infrastructure, the increasing prevalence of chronic diseases, and the rising demand for safe and cost-effective healthcare solutions. The region's large and growing population, particularly in countries like China and India, is driving the demand for disposable syringes.

The expansion of healthcare access in emerging markets, alongside government initiatives to improve healthcare systems, is propelling the disposable syringes market. Additionally, the increasing adoption of self-injection therapies in countries such as India and China is contributing to the higher growth rates in the region. The Asia-Pacific market is expected to continue expanding, supported by rising healthcare awareness and the growing demand for vaccinations and disease management solutions.

Competitive Landscape and Leading Companies

The disposable syringes market is highly competitive, with several global players dominating the industry. Leading companies such as Becton, Dickinson and Company (BD), Terumo Corporation, and Medtronic continue to innovate and expand their product offerings. These companies are focusing on technological advancements in syringe design, including safety features such as needle shields and retractable needles to enhance patient safety.

The market also sees significant competition from regional players in Asia-Pacific, where demand is expanding rapidly. Companies are increasingly investing in production facilities and expanding their product portfolios to cater to the growing demand for disposable syringes. Strategic partnerships, mergers, and acquisitions are common as companies look to strengthen their market position and gain a competitive edge in the rapidly growing global market for disposable syringes.

This overview of the disposable syringes market reveals the diversity and complexity of the industry. Each segment plays a crucial role in ensuring the effective delivery of medical treatments worldwide, with innovations in syringe design and safety features paving the way for the next generation of drug delivery devices. The market's growth is driven by increasing healthcare needs, especially in emerging regions, where disposable syringes are becoming essential for disease management, vaccination programs, and chronic illness treatment.

Recent Developments:

• Becton, Dickinson and Company (BD) announced the launch of its BD Neostar Safety Syringe, designed to enhance user safety during vaccinations and other injections.
• Terumo Corporation recently expanded its disposable syringe manufacturing facility in the United States to meet the growing demand for safe and efficient injection devices.
• Medtronic received FDA approval for a new line of pre-filled disposable syringes that improve ease of use for insulin-dependent patients.
• Fresenius Kabi launched single-use prefilled syringes for anesthesia, offering a more efficient and sterile method for administering medications.
• Nipro Corporation entered into a strategic partnership with a leading pharmaceutical company to develop advanced disposable syringes for drug delivery, focusing on expanding its product range for chronic disease management

List of Leading Companies:

• Becton, Dickinson and Company (BD)
• Terumo Corporation
• Medtronic
• Smiths Group
• Fresenius Kabi AG
• Nipro Corporation
• Gerresheimer AG
• Hindustan Syringes & Medical Devices Ltd.
• Schott AG
• Steris Corporation
• Embulife
• Abbott Laboratories
• Alcon
• Syringe Supplies
• B. Braun Melsungen

Report Scope: